Eupatilin suppresses osteoclastogenesis and periodontal bone loss by inhibiting the MAPKs/Siglec-15 pathway.

Saved in:
Bibliographic Details
Title: Eupatilin suppresses osteoclastogenesis and periodontal bone loss by inhibiting the MAPKs/Siglec-15 pathway.
Authors: Zhao, Boxuan1 (AUTHOR), Chen, Zhiyong1 (AUTHOR), Li, Ting1 (AUTHOR), Yao, Hantao1 (AUTHOR), Wang, Zijun1 (AUTHOR), Liao, Yilin1 (AUTHOR), Guo, Haiying1 (AUTHOR), Fu, Dongjie2 (AUTHOR), Ji, Yaoting1 (AUTHOR) yaotingji@whu.edu.cn, Du, Minquan1 (AUTHOR) duminquan@whu.edu.cn
Source: International Immunopharmacology. Sep2024, Vol. 139, pN.PAG-N.PAG. 1p.
Database: Academic Search Ultimate
Description
ISSN:15675769
DOI:10.1016/j.intimp.2024.112720